Specifically, they compared the miR profiles of CD133+ and CD133− subpopulations from two Ewing Sarcoma tumors, pediatric MSCs stably expressing retrovirally introduced EWS/Fli1, and one Ewing Sarcoma cell line (STA-ET-8.2). The gene discussed is EWSR1; the disease is Ewing sarcoma.